Search Within

Robert Motzer

  1. "Body Imaging Service"
Formats
  1. Journal Article (59)
  2. Meeting Abstract (32)
  3. Conference Paper (1)
  4. Research Letter (1)
Groups
  1. Body Imaging Service (93)
  2. Department of Medicine (93)
  3. Genitourinary Oncology Service (93)
  4. Radiology, Department of (93)
  5. Solid Tumor Oncology Division (93)
  6. Epidemiology and Biostatistics (43)

More Groups

People
  1. Darren Feldman (47)
  2. Martin Voss (37)
  3. Sujata Patil (33)
  4. Chung-Han Lee (30)
  5. Michelle Ginsberg (30)
  6. Lawrence Schwartz (23)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (4)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (39)
  2. Investigational New Drugs (12)
  3. Clinical Genitourinary Cancer (5)
  4. Cancer (4)
  5. American Journal of Hematology/Oncology (3)
  6. Clinical Cancer Research (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (39)
  2. Springer (12)
  3. Elsevier Inc. (8)
  4. American Association for Cancer Research (5)
  5. Wiley Blackwell (5)
  6. Elsevier Science, Inc. (4)

More Publishers

Results (93)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of thalidomide for patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Berg, W.; Ginsberg, M.; Russo, P.; Vuky, J.; Yu, R. R.; Bacik, J.; Mazumdar, M.
    Journal of Clinical Oncology (2002)

    Fulltext@MSK | Save
  • Randomized multicenter phase II trial of subcutaneous recombinant human interleukin-12 versus interferon-α2a for patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Rakhit, A.; Thompson, J. A.; Nemunaitis, J.; Murphy, B. A.; Ellerhorst, J.; Schwartz, L. H.; Berg, W. J.; Bukowski, R. M.
    Journal of Interferon and Cytokine Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Rakhit, A.; Ginsberg, M.; Rittweger, K.; Vuky, J.; Yu, R.; Fettner, S.; Hooftman, L.
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save
  • Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma
    Journal Article

    Berg, W. J.; Schwartz, L.; Yu, R.; Mazumdar, M.; Motzer, R. J.
    Investigational New Drugs (2001)

    Fulltext@MSK | Save
  • Phase I study of a 40kDa branched pegylated-interferon alpha-2a (PEGASYS (TM)) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Motzer, R.; Berg, W.; Rakhit, A.; Ginsberg, M.; Rittweger, K.; Fettner, S.; Yu, R.; Hooftman, L.
    Annals of Oncology (2000)

    Fulltext@MSK | Save
  • Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Murphy, B. A.; Bacik, J.; Schwartz, L. H.; Nanus, D. M.; Mariani, T.; Loehrer, P.; Wilding, G.; Fairclough, D. L.; Cella, D.; more...
    Journal of Clinical Oncology (2000)

    Fulltext@MSK | Save
  • Phase II trial of pyrazoloacridine in patients with cisplatin-refractory germ cell tumors
    Journal Article

    Vuky, J.; McCaffrey, J.; Ginsberg, M.; Mariani, T.; Bajorin, D. F.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2000)

    Fulltext@MSK | Save
  • A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma
    Journal Article

    Berg, W. J.; McCaffrey, J.; Schwartz, L. H.; Mariani, T.; Mazumdar, M.; Motzer, R. J.
    Investigational New Drugs (1998)

    Fulltext@MSK | Save
  • Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Rakhit, A.; Schwartz, L. H.; Olencki, T.; Malone, T. M.; Sandstrom, K.; Nadeau, R.; Parmar, H.; Bukowski, R.
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • A phase II study of 13-cis-retinoic acid in patients with advanced renal cell carcinoma
    Journal Article

    Berg, W. J.; Schwartz, L. H.; Amsterdam, A.; Mazumdar, M.; Vlamis, V.; Law, T. M.; Nanus, D. M.; Motzer, R. J.
    Investigational New Drugs (1997)

    Fulltext@MSK | Save